The study shows that cirrhosis is complicated by a high rate of PVT and thatprevious PVT is an independent predictor not only of PVT recurrence but also of low survival. The study opens potentially novel therapeutic scenarios as the association between PVT and poor outcomes would provide a rationale to plan interventional trials with anti-thrombotic drugs. A recent metaanalysis on this topic22 suggested a potential usefulness of anticoagulants in improving outcomes of PVT but randomized controlled trials are necessary to support thisfinding. The PROLIVER study has been performed in a single country, enrolling only Caucasians, limiting the generalizability of the findings to cirrhotic patients from other countries or ethnic groups. In conclusion, PVT is a frequent complication of cirrhosis and its early diagnosis would be helpful to identify patients at risk of poor clinical outcomes

Incidence and recurrence of portal vein thrombosis in cirrhotic patients / Violi, Francesco; Corazza, Gino Roberto; Caldwell, Stephen H; Talerico, Giovanni; Romiti, Giulio Francesco; Napoleone, Laura; Perticone, Francesco; Bolondi, Luigi; Pietrangelo, Antonello; Vestri, Anna Rita; Raparelli, Valeria; Basili, Stefania; PRO-LIVER, Collaborators; Visioli, Giacomo. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 119:3(2019), pp. 496-499. [10.1055/s-0038-1676981]

Incidence and recurrence of portal vein thrombosis in cirrhotic patients

Violi, Francesco
;
Talerico, Giovanni;Romiti, Giulio Francesco;Napoleone, Laura;Vestri, Anna Rita;Raparelli, Valeria;Basili, Stefania;Visioli, Giacomo
Membro del Collaboration Group
2019

Abstract

The study shows that cirrhosis is complicated by a high rate of PVT and thatprevious PVT is an independent predictor not only of PVT recurrence but also of low survival. The study opens potentially novel therapeutic scenarios as the association between PVT and poor outcomes would provide a rationale to plan interventional trials with anti-thrombotic drugs. A recent metaanalysis on this topic22 suggested a potential usefulness of anticoagulants in improving outcomes of PVT but randomized controlled trials are necessary to support thisfinding. The PROLIVER study has been performed in a single country, enrolling only Caucasians, limiting the generalizability of the findings to cirrhotic patients from other countries or ethnic groups. In conclusion, PVT is a frequent complication of cirrhosis and its early diagnosis would be helpful to identify patients at risk of poor clinical outcomes
2019
portal vein thrombosis; liver-transplantation; risk-factors; coagulopathy; mortality; outcomes
01 Pubblicazione su rivista::01f Lettera, Nota
Incidence and recurrence of portal vein thrombosis in cirrhotic patients / Violi, Francesco; Corazza, Gino Roberto; Caldwell, Stephen H; Talerico, Giovanni; Romiti, Giulio Francesco; Napoleone, Laura; Perticone, Francesco; Bolondi, Luigi; Pietrangelo, Antonello; Vestri, Anna Rita; Raparelli, Valeria; Basili, Stefania; PRO-LIVER, Collaborators; Visioli, Giacomo. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - 119:3(2019), pp. 496-499. [10.1055/s-0038-1676981]
File allegati a questo prodotto
File Dimensione Formato  
Violi_Incidence_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 127.35 kB
Formato Adobe PDF
127.35 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1272777
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 35
social impact